ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$196.65

Market cap

$31.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$28.51

Enterprise value

$32.58B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's debt has increased by 17% YoY but it has decreased by 14% QoQ
The equity has decreased by 39% YoY
The quick ratio has contracted by 28% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PACB A TMO DHR

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
158.1M
Market cap
$31.09B
Enterprise value
$32.58B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.64
Price to sales (P/S)
6.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.33
Earnings
Revenue
$4.45B
EBIT
-$4.51B
EBITDA
-$4.1B
Free cash flow
-$47M
Per share
EPS
-$28.51
Free cash flow per share
-$0.3
Book value per share
$42.36
Revenue per share
$28.15
TBVPS
$33.77
Balance sheet
Total assets
$11.81B
Total liabilities
$5.12B
Debt
$2.98B
Equity
$6.69B
Working capital
$942M
Liquidity
Debt to equity
0.45
Current ratio
1.42
Quick ratio
0.98
Net debt/EBITDA
-0.36
Margins
EBITDA margin
-92.3%
Gross margin
63.2%
Net margin
-100.9%
Operating margin
-99.6%
Efficiency
Return on assets
-35.4%
Return on equity
-58.9%
Return on invested capital
-113.2%
Return on capital employed
-47.1%
Return on sales
-101.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
1.1%
1 week
-7.52%
1 month
-4.33%
1 year
-17.88%
YTD
-2.74%
QTD
-15.44%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.45B
Gross profit
$2.81B
Operating income
-$4.43B
Net income
-$4.49B
Gross margin
63.2%
Net margin
-100.9%
The company's gross profit fell by 12% YoY and by 5% QoQ
Illumina's operating margin has decreased by 9% from the previous quarter
The gross margin has contracted by 8% YoY and by 2.5% from the previous quarter
The operating income has decreased by 6% from the previous quarter

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
ILMN P/E details
P/E
N/A
P/B
4.64
P/S
6.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.33
The price to book (P/B) is 50% lower than the 5-year quarterly average of 9.2 but 4.3% higher than the last 4 quarters average of 4.4
The equity has decreased by 39% YoY
ILMN's P/S is 46% below its 5-year quarterly average of 12.8
Illumina's revenue has decreased by 4.5% YoY and by 3% QoQ

Efficiency

How efficient is Illumina business performance
The ROE has contracted by 16% from the previous quarter
The company's return on assets fell by 9% QoQ
Illumina's return on sales has decreased by 8% QoQ
ILMN's return on invested capital is down by 5% since the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 131% more than the total liabilities
The quick ratio has contracted by 28% YoY
The total assets has contracted by 23% YoY and by 3.6% from the previous quarter
Illumina's debt is 55% lower than its equity
The debt to equity has soared by 96% year-on-year but it is down by 15% since the previous quarter
The equity has decreased by 39% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.